Matt Popkin GSK on behalf of EFPIA

Matt Popkin GSK to work as synthetic chemist in 2000. Since that time he has worked in a number of R&D roles in the CMC development and registration of novel medicines, leading teams focused on QbD, innovative manufacturing, and new technologies and innovative regulatory science, including as part of ICH Quality working groups.  In his current role he is Executive Director, CMC Excellence, within CMC Regulatory Affairs based in the UK. In this role, Matt is head of global CMC policy and advocacy in GSK  and is vice-chair of the Manufacturing and Quality Expert Group at the European Federation of Pharmaceutical Industries and Associations (EFPIA).